Castration-resistant Prostate Cancer Clinical Trials
3 recruiting trials for Castration-resistant Prostate Cancer. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT07259213
A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
A Phase 1/2a Study to Evaluate the Safety, Tolerability, Whole-Body Distribution, and Preliminary Clinical Activity of 161Tb-RAD402, a Radiolabeled Anti-KLK3 Monoclonal Antibody...
Sponsor: Radiopharm Theranostics, LtdEnrolling: 732 locations
RECRUITINGPhase 1NCT06895811
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
This is a single-arm, single-center, open-label clinical trial designed to evaluate the clinical safety and tolerability of different doses of Prostate-Specific Membrane Antigen...
Sponsor: Shanghai Changzheng HospitalEnrolling: 31 location
RECRUITINGPhase 1NCT06966024
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
This is a multicenter clinical trial to evaluate the safety and preliminary activity of the selective general control nonderepressible 2 (GCN2) activator DCC-2812 as monotherapy...
Sponsor: Deciphera Pharmaceuticals, LLCEnrolling: 603 locations